Cenix BioScience Signs Research Service Agreement with Bayer Pharma AG Cenix BioScience GmbH announced that is has signed a research service agreement with Bayer Pharma AG. Under the agreement, Cenix will undertake a target discovery project for an undisclosed disease indication by applying its longstanding industry-leading expertise in high throughput RNAi for genome-scale screening in advanced cell models. [Cenix BioScience GmbH] Press Release AstraZeneca Initiates Phase III Immunotherapy Study for MEDI4736 in Patients with Lung Cancer AstraZeneca announced the start of the Phase III program for MEDI4736, an immunotherapy in development for the treatment of non-small cell lung cancer and other cancers. [AstraZeneca] Press Release Advaxis to Initiate Clinical Development of ADXS-cHER2 Immunotherapy to Treat Pediatric Bone Cancer Advaxis, Inc. announced it intends to initiate a clinical development program with its product candidate, ADXS-cHER2, for the treatment of pediatric osteosarcoma. ADXS-cHER2 is an immunotherapy that targets the HER2 oncogene, which is overexpressed in certain solid-tumor cancers, including pediatric bone cancer and breast cancer. [Advaxis, Inc.] Press Release Americord Funds Clinical Trial Investigating Stem Cell Therapy for Alzheimer’s Disease Americord announced that it has provided funding to MEDIPOST to support their clinical trial investigating the use of NEUROSTEM-AD® in the treatment of patients with Alzheimer’s Disease. NEUROSTEM-AD® is a treatment agent for Alzheimer’s Disease that uses human umbilical cord blood-derived mesenchymal stem cells. [Americord Registry] Press Release $4 Million from Eli and Edythe Broad Foundation will Support UCLA Research Two new gifts from The Eli and Edythe Broad Foundation to UCLA totaling $4 million will fund research in stem cell science and digestive diseases and support the recruitment of key faculty at two renowned research centers. [UCLA] Press Release Medical College of Wisconsin Receives Grant from National Cancer Institute to Develop Novel Cellular Immunotherapy The Medical College of Wisconsin has received a five-year, $1.6 million grant from the National Institutes of Health’s National Cancer Institute to support development of novel immune cell-based therapies to cancer. [Medical College of Wisconsin] Press Release biOasis Delivers siRNA to the Brain Using Its Transcend Peptide Vector biOasis Technologies Inc. has shown that a newly discovered peptide vector form of Transcend – Transcendpep – effectively delivers siRNA across the blood-brain barrier and into brain cells. [biOasis Technologies Inc.] Press Release STEMCELL Technologies Inc. Has Just Released NEW MesenCult™ Proliferation Kit with MesenPure™ (Mouse), a Novel Cell Culture Medium to Advance Research on Mouse Mesenchymal Stem and Progenitor Cells (MSCs) MesenCult™ Proliferation Kit with MesenPure™ (Mouse) is a novel cell culture medium to advance research on mouse mesenchymal stem and progenitor cells (MSCs). [STEMCELL Technologies Inc.] Press Release Xcelthera Inc. Secures First U.S. Patent for Large-Scale Production of High Quality Human Embryonic Stem Cells and Their Neuronal and Heart Muscle Cell Therapy Products Xcelthera Inc. and its joint research partner San Diego Regenerative Medicine Institute announced the U.S. Patent and Trademark Office has granted Patent No. 8,716,017 entitled “Technologies, Methods, and Products of Small Molecule-Directed Tissue and Organ Regeneration from Human Pluripotent Stem Cells”. [Xcelthera Inc.] Press Release |